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Abstract
Background: Hypoxia inducible factor (HIF)-1 is the key transcriptional factor involved in the adaptation process of cells and
organisms to hypoxia. Recent findings suggest that HIF-1 plays also a crucial role in inflammatory and infectious diseases.
Methodology/Principal Findings: Using patient skin biopsies, cell culture and murine infection models, HIF-1 activation was
determined by immunohistochemistry, immunoblotting and reporter gene assays and was linked to cellular oxygen
consumption. The course of a S. aureus peritonitis was determined upon pharmacological HIF-1 inhibition. Activation of HIF-
1 was detectable (i) in all ex vivo in biopsies of patients suffering from skin infections, (ii) in vitro using cell culture infection
models and (iii) in vivo using murine intravenous and peritoneal S. aureus infection models. HIF-1 activation by human
pathogens was induced by oxygen-dependent mechanisms. Small colony variants (SCVs) of S. aureus known to cause
chronic infections did not result in cellular hypoxia nor in HIF-1 activation. Pharmaceutical inhibition of HIF-1 activation
resulted in increased survival rates of mice suffering from a S. aureus peritonitis.
Conclusions/Significance: Activation of HIF-1 is a general phenomenon in infections with human pathogenic bacteria,
viruses, fungi and protozoa. HIF-1-regulated pathways might be an attractive target to modulate the course of life-
threatening infections.
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Introduction
Mammalian cells adapt to oxygen deprivation by the activation
of hypoxia inducible factor (HIF)-1, the key transcription factor during
hypoxia. Subsequently, the expression of hypoxia-inducible genes
involved in angiogenesis [e.g., vascular endothelial growth factor
(VEGF)], glycolysis [e.g., hexokinase (HK)], proliferation and
survival [e.g., adrenomedullin (ADM)] and erythropoiesis (e.g.,
erythropoietin) is transcriptionally regulated [1,2]. The heterodi-
meric transcription factor HIF-1 is composed of the two subunits
HIF-1a and HIF-1b. While HIF-1b is constantly present in the
nucleus, HIF-1a levels are affected by changes in the cellular
oxygen partial pressure (pO2). The key mechanism involved in
HIF-1 activation has been identified to require inhibition of the
enzymatic activity of ‘‘prolyl hydroxylase domain’’-containing
proteins (PHDs) during hypoxia. PHDs mediate hydroxylation of
the prolyl residues Pro402 and Pro564 of the HIF-1a subunit
which results in the binding to the von-Hippel-Lindau protein and
subsequent proteasomal degradation under normoxic conditions.
In contrast, hypoxia results in PHD-inhibition and subsequent
stabilization of HIF-1a, binding of the HIF-1 heterodimer to
promoter regions of hypoxia-inducible genes and corresponding
gene induction [2]. Iron deprivation [induced by iron chelating
compounds, e.g., desferrioxamine (DFO)] has been found an
alternative strategy of HIF-1 activation [3]. The molecular
explanation for this phenomenon is that PHDs contain iron as
an essential cofactor for their enzymatic activity; therefore, iron
chelation inhibits PHD activity resulting in the subsequent
activation of HIF-1 [4].
A constantly growing body of evidence suggests that HIF-1
plays a novel and important role in infectious and inflammatory
diseases [5]. HIF-1 is essential for the bactericidal capacity of
phagocytes and for controlling systemic spread of bacteria in mice
[5,6]. Interestingly, HIF-1 activation occurs during bacterial
infections with the angiogenic bacterium Bartonella henselae (causing
the vasculoproliferative disorder bacillary angiomatosis) [7] and
this phenomenon is linked with the expression of the Bartonella
adhesin A [8–10]. In infections with humanpathogenic Enterobac-
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bacteria and host cells caused by secreted bacterial siderophores;
here, HIF-1 plays an important role in the defense of Yersinia
enterocolitica infections [11]. Using keratinocytes, it was recently
demonstrated that HIF-1 activation results in the expression of
cathelicidin, an antimicrobial peptide mediating protection against
gram positive group A streptococci [6]. LPS from gram negative
bacteria can trigger HIF-1 activation in macrophages [12,13] and
this HIF-1 activation is crucial for the development of a LPS
triggered sepsis [14,15]. Interestingly, LPS-dependent HIF-1
activation does not occur using epithelial or endothelial cell-based
infection models [9–11].
Although several aspects have been analyzed in the last years,
the exact role of HIF-1 in the course of infection with human
pathogens remains widely unclear. Therefore, we investigated the
activation of HIF-1 in infections with human pathogens more
generally using human skin biopsies, cell culture techniques and by
employing Staphylococcus aureus infection models. Our data reveal
that HIF-1 might play an important and previously underestimat-
ed role in many infectious diseases.
Results
Activation of HIF-1 by human pathogens is a general
phenomenon in infections
First, we analyzed ex vivo whether pathogen-triggered HIF-1
activation is detectable in biopsy samples of patients suffering from
various bacterial, viral, fungal or parasitic skin infections. For this
purpose, paraffin-embedded patient skin biopsies were collected
according to the following strict inclusion criteria: (a) a clinically
suspected infectious process, (b) the histopathological diagnosis of
an infection (no malignancy, no autoimmunological disease) and
(c) a microbiologically positive laboratory result confirming the
presence of specific pathogens in the lesions. In total, four samples
of bacterial skin infections, two samples of viral skin infections,
three samples of fungal skin infections and two samples of
protozoic skin infections were investigated by HIF-1a-specific
immunohistochemistry (Fig. 1). In control samples (healthy
patients, bioptic sample taken for other reasons, Fig. 1A), a rare
and faint nuclear HIF-1a staining occurred in the epidermis
whereas the dermis was negative for HIF-1a. In contrast, in all
cutaneous infections [here: infections with S. aureus (Fig. 1B),
coinfection with S. agalactiae and S. aureus (Fig. 1C), coinfection
with Acinetobacter baumanii and E. coli (Fig. 1D), infections with
Borellia burgdorferi (Fig. 1E), Varicella zoster virus (Fig. 1F),
Human Herpes Virus-8 (Fig. 1G), Tinea rubrum (Fig. 1H,I), C.
albicans (Fig. 1J) and Leishmania donovani (Fig. 1K,L)] a strong
nuclear HIF-1a signal was detected in keratinocytes (predomi-
nantly of the spinal cell layer), dermal capillaries, neutrophils,
dermal lymphocytes and macrophages and sub-corneal neutro-
phils (for details please see legend of Fig. 1).
Activation of HIF-1 in host cells upon infections with B. henselae
and several members of the family of Enterobacteriaceae is triggered
by oxygen-dependent and -independent mechanisms [7,11]. Now,
we were interested whether and by which mechanisms various
human pathogens lead to the activation of HIF-1 in host cells. For
this purpose, we infected HeLa-229 cells and NHEKs (Normal
Human Epidermal Keratinocytes) with a collection of bacterial
pathogen reference strains (S. aureus ATCC 33592, S. epidermidis
ATCC 12228, E. coli ATCC 25922, P. aeruginosa ATCC 27853, S.
agalactiae SK 43) and with the fungal pathogen C. albicans ATCC
90028. In all these in vitro infection models, a robust activation of
HIF-1 was detectable via HIF-1a immunoblotting (Fig. 2, 3) and
congruent results were obtained via immunohistochemistry using
Hela-229 cells grown on coverslips (Fig. S1, not all data shown).
HIF-1 activation was correlated with increased oxygen consump-
tion of the respective infected host cells strongly arguing for
oxygen-dependent HIF-1 activation mechanisms. This suggestion
is confirmed by the observation that HIF-1 activation by S. aureus,
P. aeruginosa and E. coli was overcome by culturing infected cells in
gas-permeable dishes (data not shown). Accordingly, induction of
the HIF-1-regulated VEGF was detected in bacterial infections
with S. aureus, P. aeruginosa and E. coli by VEGF mRNA induction
whereas HIF-1a mRNA transcript levels itself again appeared
unaffected (Fig. S2). Infections with S. pyogenes did not lead to
oxygen consumption nor HIF-1 activation (data not shown).
Infection of host cells with S. aureus results in HIF-1-
regulated gene programming
Infection of host cells with B. henselae or Enterobacteriaceae (Y.
enterocolitica, Enterobacter aerogenes, Salmonella enterica) results in the
activation of HIF-1 and a subsequent HIF-1-dependent angio-
genic gene programming in vitro and in vivo [7,9–11]. As HIF-1
activation was also detectable in infections with S. aureus (see
above), a clinically most important pathogen, we focussed on this
bacterium to elucidate which mechanisms and which biological
consequences underlie this process.
First, we infected HeLa-229 cells with a well characterized S.
aureus laboratory strain (8325-4). Such infection led to a robust HIF-
1 activation and HIF-1 dependent VEGF induction shown by HIF-
1a-immunoblotting, HIF-1-dependent luciferase reporter assays
and quantitative PCR analysis (Fig. 4A, B, C). HIF-1a mRNA
transcript levels itself were unaffected (Fig. 4D) excluding direct
effects of S. aureus on HIF-1 transcription but suggesting oxygen-
dependent posttranslational mechanisms of HIF-1 activation.
Next, we introduced a genetically defined small colony variant
of S. aureus (S. aureus DhemB) and the S. aureus DhemB hemB-
complemented strain (S. aureus pCX19VhemB) in our experiments.
S. aureus DhemB shows a small-colony phenotype and is
auxotrophic for the synthesis of hemin [16]. Therefore, as hemin
is essential for the biosynthesis of cytochromes, S. aureus DhemB is
deficient in aerobic metabolism [17]. Interestingly, S. aureus DhemB
was neither capable in activating HIF-1 nor in VEGF induction
whereas the complemented strain was fully restored in its
biological effects (oxygen consumption, HIF-1 activation and
VEGF induction) suggesting oxygen-dependent mechanisms in the
activation of HIF-1 by S. aureus. Furthermore, S. aureus strains
defective in certain cell wall components known to be important
for pathogenicity [e.g., lipoteichoic acid [18], wall teichoic acid
[19], extracellular adherence protein [20]] were not impaired in
their ability of inducing HIF-1 activation (Fig. 5).
To exclude that the above described phenomenon might be
restricted to this particular S. aureus laboratory strain, we employed
several other S. aureus small colony variants (clinical SCVs)
originating from patients suffering from chronic infections and
their respective parental wild-type strain (Fig. 6, not all data
shown). Data clearly revealed that only wild-type but not clinical
SCV bacteria lead to the activation of HIF-1 underlining the
general aspect of our observations. Further analysis revealed that
the clinical SCV S. aureus OM 1b is auxotrophic for menadione
[21] and S. aureus A22223 II is unable to synthesize hemin [22].
Both auxotrophies are linked to the activity of the electron
transport chain and affect thereby the aerobic metabolism.
To prove whether HIF-1 activation by S. aureus is an oxygen-
dependent process, we determined cellular hypoxia upon a
bacterial infection using a hypoxia-sensitive dye and by quantifi-
cation of the dissolved O2 concentration in cell culture
supernatants. In fact, cellular hypoxia occured in infections with
HIF-1 Activation by Pathogens
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but not when cells were infected with S. aureus DhemB. Here, a
significantly increased oxygen consumption in cells infected with S.
aureus 8325-4 and the S. aureus DhemB hemB-complemented strain
was detectable (Fig. 7A, B). To analyze whether such HIF-1
activation by S. aureus might be overcome by oxygen, an infection
model using conventional versus gas-permeable cell culture dishes
was introduced allowing to investigate oxygen-dependent and -
independent mechanisms of HIF-1 activation. As expected,
activation of HIF-1 by S. aureus 8325-4 and the S. aureus DhemB
Figure 1. Detection of HIF-1 activation in human skin biopsies of patients suffering from cutaneous infections by
immunohistochemistry. (A) In uninfected skin, rare and faint nuclear HIF-1a staining occurred in the epidermis whereas the dermis was
negative for HIF-1a (A1). (B to L) In all cutaneous infections, a strong nuclear HIF-1a signal was detected in keratinocytes, predominantly of the spinal
cell layer (examplified in L). Moreover, endothelial cells of dermal capillaries frequently stained positive (arrows in B1, C1, D1, E1, G, I1). Arrowheads:
(B2) border zone of the positive abscess; (C2): positive neutrophils; (F): positive dermal lympho-histiocytic infiltrates; (F1): large positive nuclei of a
multi-nuclear giant cell; (F2): skin lesion surrounded by a HIF-1 positive inflammatory infiltrate; (H): positive sub-corneal neutrophils (higher power in
H1); (I): positive intra-epidermal infiltrate; (K): intradermal nodules containing leishmaniae. (A) Control: uninfected sample; (B–E): bioptic samples of
patients suffering from infections with humanpathogenic bacteria [(B) S. aureus, (C) S. agalactiae and S. aureus, (D) A. baumanii and E. coli and (E) B.
burgdorferi], (F, G) with humanpathogenic Herpes-viruses [(F) Varicella zoster virus (VZV) and (G) Human Herpes Virus-8 (HHV 8)], (H–J) with
humanpathogenic fungi [(H+I) T. rubrum and (J) C. albicans] or (K, L) with the protozoic pathogen L. donovani. Magnifications: all 2506, except for A1,
B1, B2, C1, D1, E1, F2, I1 (all 4006), and C2, F1, H1, L (all 1,0006).
doi:10.1371/journal.pone.0011576.g001
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PLoS ONE | www.plosone.org 3 July 2010 | Volume 5 | Issue 7 | e11576Figure 2. Oxygen-dependent HIF-1 activation in HeLa-229 cells and NHEKs (Normal Human Epidermal Keratinocytes) by bacterial
and fungal pathogens. Four to six hours upon infection, HIF-1 activation was determined by Western blotting (loading control: actin). pO2 levels
were quantified in the medium of control and infected cells (A: S. aureus ATCC 33592, MOI 20, infection time: six hours; B: S. epidermidis ATCC 12228,
MOI 20, infection time: six hours; C: E. coli ATCC 25992, MOI 10, infection time: four hours). Negative control: uninfected cells, positive control: hypoxia
or DFO (200 mmol/L).
doi:10.1371/journal.pone.0011576.g002
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PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11576Figure 3. Oxygen-dependent HIF-1 activation in HeLa-229 cells and NHEKs (Normal Human Epidermal Keratinocytes) by bacterial
and fungal pathogens. Four to six hours upon infection, HIF-1 activation was determined by Western blotting (loading control: actin). pO2 levels
were quantified in the medium of control and infected cells (D: P. aeruginosa ATCC 27853, MOI 10, infection time: four hours; E: S. agalactiae SK 43,
MOI 200, infection time: five hours; F: C. albicans ATCC 90028, MOI 20, infection time: six hours). Negative control: uninfected cells, positive control:
hypoxia or DFO (200 mmol/L).
doi:10.1371/journal.pone.0011576.g003
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dishes and this correlated clearly with the oxygen partial pressure
in the respective cell culture supernatants. For S. aureus DhemB no
HIF-1 activation nor oxygen consumption was detectable in
infected host cells (Fig. 7C, D). Taken together, these results show
that (i) S. aureus wildt-ype but not S. aureus SCV induces a HIF-1
regulated gene programming in host cells and that (ii) HIF-1
activation is in fact an oxygen dependent process.
Finally, we employed a murine intravenous S. aureus infection
model in which the S. aureus bacteremia results in kidney abscess
formation [23]. After seven days upon infection, macroscopically
visible kidney abscesses occurred. Kidneys were removed, fixed
and embedded in paraffin. Serial sections were processed by
hematoxylin-eosin (H&E)- and HIF-1 staining. Massive abscess
formation was also detected in H&E staining (Fig. 8B) and HIF-
1a positive nuclei were most abundant in the abscess-surrounding
areas (Fig. 8A). HIF-1 activation was also detectable in the
peritoneum of mice suffering from a S. aureus-peritonitis (see
below).
Taken together, we conclude from the above described in vitro,
ex vivo and in vivo data that HIF-1 activation is a general
phenomenon in infections with human pathogenic bacteria,
viruses, fungi and protozoae and that this phenomenon is most
likely due to hypoxic signaling.
Inhibition of HIF-1 by 17-DMAG increases survival of mice
in a S. aureus peritonitis model
Mice are highly susceptible for a S. aureus peritonitis [24]. For
this purpose, we infected mice intraperitoneally with S. aureus wild-
Figure 4. Induction of HIF-1-dependent gene programming in
HeLa-229 cells by different S. aureus strains. Six hours upon
infection, HIF-1 activation was analyzed in (A) Western blots (loading
control: actin) and by determining (B) the induction of the HIF-1-
dependent luciferase activity. HeLa-229 cells were transfected with a
4xHRE-luc reporter construct 24 hours before infection (triplicate means
given; for details see Material and Methods). Induction was determined
by chemiluminescence. Bacterial induced (C) VEGF and (D) HIF-1a
transcription. Total mRNA was prepared six hours upon infection,
transcribed into cDNA and quantified by real-time Light-Cycler-PCR
(ratio: VEGF/actin or HIF-1a/actin transcripts; triplicate means given).
Negative control: uninfected cells; S. aureus wt (8325-4); S. aureus
DhemB (S. aureus ermBVhemB 8325-4, SCV); S. aureus DhemB, hemB-
complemented (S. aureus pCX19VhemB 8325-4, complemented SCV
mutant) [16]; positive control: DFO (200 mmol/L). Multiplicity of
infection (MOI): 20. * significant difference to control cells (P,0.05).
doi:10.1371/journal.pone.0011576.g004
Figure 5. Induction of HIF-1 activation in HeLa-229 cells by
different S. aureus strains defective in the expression of cell
wall components. The HIF-1a protein was analyzed in Western blots
six hours upon infection (loading control: actin) of HeLa 229 cells with
the following bacterial strains: (A) S. aureus 8325-4 (wt), S. aureus
ermBVhemB 8325-4 (SCV), S. aureus SA113 (wt), S. aureus SA113
Dypf::ermB (reduced in lipoteichoic acid synthesis), S. aureus SA113
DtagO (defective in producing wall teichoic acid); (B) S. aureus ATCC
25923 (wt), S. epidermidis ATCC 12228 (wt), S. aureus Newman (wt), S.
aureus Newman mAH12 (defective in producing the extracellular
adherence protein EAP). Negative control: uninfected cells, positive
control: DFO (200 mM). Multiplicity of infection (MOI): 20.
doi:10.1371/journal.pone.0011576.g005
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related S. aureus SCV (S. aureus ermBVhemB) strain (not activating
HIF-1, see above) did not cause such a massive infection as all
mice (n=8) survived this infection (Fig. 9A).
As only S. aureus wild-type and not S. aureus SCV infections led to
the activation of HIF-1 in vitro (see above), we finally analyzed the
biological role of HIF-1 in this infection model. 17-DMAG is
known to be a potent HIF-1 inhibitor [25]. Therefore we first
established experiments elucidating the inhibition of HIF-1
activation by 17-DMAG in our experimental in vitro setting. In
fact, addition of 17-DMAG prevented the activation of HIF-1 by
DFO in a dose-dependent manner. A minimum concentration of
10 mmol/L 17-DMAG was effectual for inhibition of DFO-
induced HIF-1 activation (Fig. 9B, not all data shown).
In vivo, the administration of 17-DMAG in fact prevented the
peritoneal activation of HIF-1 during infection and this phenom-
enon was accompanied by a significant better survival of mice
suffering from a S. aureus peritonitis. In detail, mice treated twice
with 17-DMAG survived to a significantly higher percentage (10/
38; 26%) compared to mice which did not receive 17-DMAG (1/
38; 3%, Fig. 9C).
Discussion
In this work, we demonstrate that HIF-1 activation in infections
with human pathogenic microorganisms is a general phenomenon
not restricted to certain pathogens. A robust and reliably
detectable HIF-1 activation was shown (i) ex vivo in biopsies of
patients suffering from skin infections, (ii) in vitro using cell culture
infection models and (iii) in vivo using murine S. aureus infection
models. Moreover, inhibition of bacterial induced HIF-1 activa-
tion resulted in higher survival rates in a S. aureus peritonitis model
suggesting that the modulation of HIF-1-regulated pathways might
influence the course of infections greatly.
In the past, hypoxia and iron-deprivation have been identified
as the major conditions leading to HIF-1 activation [2,3]. PHDs
(mainly PHD-2) were shown to represent the molecular regulators
of HIF-1 activity regulating ubiquitination and subsequent
proteasomal degradation of the HIF-1a subunit [26–28]. Accord-
ing to these observations, we demonstrated earlier that HIF-1
activation by bacteria is either the result of cellular hypoxia
following bacterial infections with e.g., B. henselae [7] or of iron-
competition between bacteria and host cells in infections with
certain Enterobacteriaceae [11]. From the herein described experi-
ments it became obvious that HIF-1 activation by pathogens is a
general phenomenon occurring in infections with bacteria, viruses,
fungi and protozoae (see Fig. 1–4). This hypothesis is supported
by various reports showing that HIF-1 activation occurs also in
infections with, e.g., Chlamydia pneumoniae [29], Helicobacter pylori
Figure 7. Cellular oxygen consumption and oxygen-dependent
HIF-1 activation in HeLa-229 cells infected with different S.
aureus strains. (A) Control and infected HeLa-229 cells were incubated
with the hypoxic marker pimonidazole hydrochloride which was
visualized by using specific Cy3 labelled antibodies (for details see
Materials and Methods). Scale bare: 40 mm. (B) pO2 levels were
quantified in the medium of control and infected cells (triplicate means
given). (C) Hela-229 cells were incubated in gas permeable (gas-perm)
and conventional (conv) culture dishes and HIF 1a protein was analyzed
in Western blots (loading control: actin). (D) pO2 levels in the medium of
control or S. aureus infected HeLa-229 cells (means of doubles).
Negative control: uninfected cells; S. aureus wt (8325-4); S. aureus
DhemB (S. aureus ermBVhemB 8325-4, SCV); S. aureus DhemB, hemB-
complemented (S. aureus pCX19VhemB 8325-4, complemented SCV
mutant). Multiplicity of infection (MOI): 20. * significant difference to
control cells (P,0.05).
doi:10.1371/journal.pone.0011576.g007
Figure 6. Induction of HIF-1 activation in HeLa-229 cells by S.
aureus patient isolates (wild-type and the respective small
colony variants). The HIF-1a protein was analyzed in Western blots
six hours upon infection (loading control: actin). The following patient
isolates were used: S. aureus patient isolate 1 (wt; S. aureus A22223 I), S.
aureus patient isolate 2 (clinical SCV; S. aureus A22223 II), S. aureus
patient isolate 3 (wt; S. aureus OM 1a), S. aureus patient isolate 4 (clinical
SCV; S. aureus OM 1b). Negative control: uninfected cells, positive
control: hypoxia. Multiplicity of infection (MOI): 20.
doi:10.1371/journal.pone.0011576.g006
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and fungal infection models (HeLa-229 cells, NHEKs), we were
able to link this HIF-1 activation with increased oxygen
consumption [via (i) pimonidazole staining, (ii) direct quantifica-
tion of oxygen partial pressure in cell culture supernatants and (iii)
by overcoming cellular hypoxia using gas-permeable cell culture
dishes, see Fig. 2, 3, 7] and strongly arguing for a role of PHD-2
and against transcriptional HIF-1 induction (excluded by quan-
tification of HIF-1a mRNA, see Fig. 4, Fig. S2). Interestingly, in
our experiments no increased HIF-2 activation was detectable
when cells were infected with P. aeruginosa, E. coli and S. aureus (data
not shown) and, until now, no reports are published indicating a
role of HIF-2 in such settings.
Infections with S. aureus strains deficient in their aerobic
metabolism [S. aureus DhemB [16], clinical S. aureus SCVs
[21,22]] did not influence the oxygen partial pressure in cell
cultures and neither led to HIF-1 activation and oxygen
consumption. HIF-1 activation was fully restored when infections
with the respective parental wild-type or genetically complement-
Figure 8. HIF-1 activation in kidneys of mice infected with S.
aureus. (A) HIF 1a immunohistochemistry and (B) hematoxilin-eosin
staining of renal mouse abscesses induced by intravenous infection
with S. aureus seven days upon infection (following sections). HIF 1a
positive nuclei are most abundant within the abscesses borders, some
interstitial staining also occurs within the renal parenchyma. In addition,
renal tubules in the vicinity of the abscess stain also positively (halfed
arrow in B). A: arcuate artery, G: glomerulus, V: arcuate vein;
arrowheads: margin of abscesses. Magnifications: (A) 2506, (B) 1006.
doi:10.1371/journal.pone.0011576.g008
Figure 9. Role of HIF-1 in infections with S. aureus in a murine
peritonitis model. (A) Survival of NMRI mice after intraperitoneal
infection with S. aureus (wt; S. aureus 8325-4; n=8) or S. aureus DhemB
(SCV, S. aureus ermVhemB 8325-4; n=8). Note the higher susceptibility
of mice infected with S. aureus 8325-4 compared to the mice infected
with S. aureus DhemB. *significant difference: P,0.001. (B) Inhibition of
DFO induced HIF-1 activation in HeLa-229 cells by 17-DMAG. Cells were
incubated with 17 DMAG (10 mmol/L) for 16 hours following induction
of HIF 1 activation by the iron chelator DFO (200 mmol/L) for six hours.
HIF 1a protein was analyzed in Western blots (loading control: actin).
Negative control: uninfected cells. (C) Survival rate of NMRI mice after
intraperitoneal infection with S. aureus (S. aureus 8325-4). One group of
mice was treated 24 h and 16 h before infection with the HIF-1
inhibiting compound 17-DMAG (25 mg/g body weight). Note the
higher survival rate of 17-DMAG-treated mice (n=45) compared with
control mice (n=45). *significant difference: P=0.005 (Kaplan-Meier
analysis).
doi:10.1371/journal.pone.0011576.g009
HIF-1 Activation by Pathogens
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wall components of S. aureus (LTA, WTA, EAP) are not involved in
HIF-1 activation (Fig. 5) arguing again for a crucial role of
infection-triggered hypoxia. Interestingly, when using a murine
peritonitis model [24], SCV-strains (deficient in their capacity of
HIF-1 activation) turned out to be non-pathogenic (see Fig. 9A).
Clinical SCVs are usually isolated from patients suffering from
chronic infections (e.g., from lung infections due to cystic fibrosis
or from osteomyelitis) [32]. It might be speculated that acute
infections (e.g., with S. aureus wild-type) are linked to a rapid and
strong HIF-1 activation whereas such activation is missing in
chronic infections (e.g., with SCV bacteria) suggesting that the
activation of HIF-1 in infections correlates directly with pathoge-
nicity and the course of infection.
Although there is solid evidence for the impact of HIF-1 on the
host response, the exact role of HIF-1 in infectious diseases is still
largely unknown. The activation of HIF-1 by bacteria was
demonstrated in vitro and ex vivo for the angiogenic bacterium B.
henselae causing the vasculoproliferative disorders bacillary angio-
matosis and peliosis hepatis [7,10]. Here, B. henselae induces an
angiogenic reprogramming of host cells via HIF-1. Infected cells
secrete angiogenic compounds (e.g. VEGF) leading to the
proliferation of endothelial cells [9], the assumed habitate of B.
henselae [33,34]. In contrast, for some members of the family of
Enterobacteriaceae (Y. enterocolitica, E. aerogenes and S. enterica spp.
enterica) an oxygen-independent HIF-1 activation was demonstrat-
ed. Here, bacterial siderophores (secreted by these Enterobacteriaceae)
compete with host cells for iron affecting PHD2-activity and
resulting in the activation of HIF-1 [11]. As mice with deletion of
HIF-1a in the intestinal epithelium showed a significant higher
susceptibility to orogastric Y. enterocolitica infections, bacterial HIF-
1 activation appears to represent a host defense mechanism [11].
In fact, HIF-1 plays an important role in cellular host defense and
innate immunity as HIF-1 is crucial for activation and stimulation
of T cells by dendritic cells [35], regulates the bactericidal capacity
of phagocytes [6] and the production of antimicrobial peptides
(e.g., cathelicidin) [14]. Such defensins of the intestinal mucosa
have been demonstrated to provide an antibacterial barrier to
prevent infections with, e.g., Enterobacteriaceae [36]. Therefore, a
lacking intestinal HIF-1 activity should finally result in a higher
susceptibility for infections with, e.g., Y. enterocolitica. Similar
mechanisms might also be operating in inflammatory bowel
diseases (IBDs) where HIF-1 regulates the barrier function of the
intestinal mucosa [37].
In contrast to the protective effect in intestinal infections, HIF-1
activation or induction of HIF-1 regulated genes seems to be
detrimental in severe systemic infections. Strongly elevated VEGF
serum levels were detected in septicaemic patients [e.g., suffering
from a methicillin-resistant S. aureus (MRSA) infection] and in
patients with severe meningitis [38–40]. HIF-1 activation was also
observed in a lipopolysaccharide (LPS)-induced murine sepsis
model [14]. Interestingly, functional blocking of serum VEGF by
soluble VEGF-receptors decreased the mortality in a LPS-
septicaemia model dramatically [15]. Concluding these observa-
tions and our results gained from the murine S. aureus peritonitis
model (Fig. 9A, C) we suggest that an overwhelming HIF-1
activation (and subsequent VEGF secretion) is detrimental in
severe infections. A mechanistic explanation for this hypothesis
might be hidden in the vasculopermeability-increasing effects of
VEGF which was originally described as vasculopermeability
factor (VPF) [41]. In fact, VEGF-dependent vascular leakage was
already demonstrated in patients suffering from septic shock [42].
Taken together, HIF-1 activation is obviously a general
phenomenon in severe infectious diseases caused largely by
hypoxia-dependent mechanisms. Our ex vivo, in vitro and in vivo
data from infections with humanpathogenic bacteria, fungi, viruses
and protozoae point towards a most important role of HIF-1 in the
host defense against various pathogens. Extensions of these
findings will determine the exact mode of HIF-1 activation by
pathogens and the related biological effects in critically ill patients.
The application of HIF-1 inhibiting compounds for the treatment
of severe infections (such as peritonitis) remains to be elucidated in
further studies.
Materials and Methods
Bacterial Strains
For in vitro experiments, the following microorganisms were
used: the laboratory strains S. aureus ATCC 33592, S. aureus 8325-
4, S. aureus ermBVhemB, S. aureus pCX19VhemB [16] S. aureus SA113,
S. aureus Newman, S. aureus ATCC 25923 and the clinical isolates
S. aureus A22223 I (wt; patient isolate 1a), S. aureus A22223 II
(clinical SCV; patient isolate 1b). S. aureus OM 1a (wt; patient
isolate 2a) and S. aureus OM 1b (clinical SCV; patient isolate 2b).
Additionally, the following strains defective in cell wall compo-
nents were used: S. aureus SA113 Dypf::ermB (about 87% reduced
lipoteichoic acid content), S. aureus SA113 DtagO (defective in
producing wall teichoic acid) and S. aureus Newman mAH12
(defective in producing the extracellular adherence protein EAP).
Other strains used for in vitro infection experiments were
Staphylococcus epidermidis ATCC 12228, Escherichia coli ATCC
25922, Pseudomonas aeruginosa ATCC 27853, Streptococcus agalactiae
SK 43 and Candida albicans ATCC 90028.
Cell Culture and Infection Procedures of HeLa-229 cells
and NHEKs
HeLa-229 cervix carcinoma cells were grown in VLE RPMI
1640 medium supplemented with 2 g/L NaHCO3 (Biochrom,
Berlin, Germany), 10% heat-inactivated fetal calf serum (FCS;
Sigma Aldrich, Taufkirchen, Germany), 1% L-glutamine (Gibco,
Karlsruhe, Germany) and 10 mg/mL streptomycine and 100 U
penicillin (Biochrom, Berlin, Germany). Normal Human Epider-
mal Keratinocytes (NHEKs) were grown in Keratinocyte Growth
Medium 2 (PromoCell, Heidelberg, Germany) supplemented with
the appropriate SupplementMix (supplied with Keratinocyte
Growth Medium 2; PromoCell), 10 mg/mL streptomycine and
100 U penicillin (Biochrom).
For performing infection experiments, cells were detached with
0.05% Trypsin-EDTA (Gibco). After trypsinization of NHEKs,
Trypsin-EDTA was neutralized by adding Trypsin Neutralizing
Solution (PromoCell). Cells were seeded the day before infection in
cell culture media without antibiotics (to allow bacterial growth).
Infection experiments were performed in cell culture media
without antibiotics and without FCS to avoid unspecific HIF-1
activation. The following pathogens were used: S. aureus, S.
epidermidis, S. pyogenes, C. albicans [multiplicity of infection (MOI):
20, infection time: six hours], S. agalactiae (MOI: 200, infection
time: six hours), E. coli, P. aeruginosa (MOI: 10, infection time: four
hours). Uninfected cells were used as negative controls, desferriox-
amine (DFO, 200 mmol/L, Sigma Aldrich) -treated cells or cells
incubated under hypoxic conditions (1% oxygen; CO2 Incubator
Innova CO-48; Eppendorf AG, Hamburg) were used as positive
controls, respectively.
For inhibition of HIF-1 activation, HeLa-229 cells were treated
with the heat shock protein (Hsp) 90-inhibitor 17-(dimethylami-
noethylamino)-17-demethoxygeldanamycin (17-DMAG; LC labo-
ratories, Woburn, MA, USA)[25]. Cells were incubated with
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adding 200 mmol/L DFO.
Detection of HIF-1 activation
For the detection of HIF-1 activation by immunoblotting,
proteins from cell cultures were extracted as described [43],
separated by 8% SDS-PAGE and blotted onto polyvinylidene
difluoride (PVDF) membranes (Millipore, Schwalbach, Germany).
Mouse anti-HIF-1a antibodies (Becton Dickinson, Heidelberg,
Germany) were used as primary antibodies and horseradish
peroxidase (HRP)-conjugated rabbit anti-mouse IgG antibodies
(Dako, Hamburg, Germany) as secondary antibodies. Signals were
visualized with the enhanced chemiluminescent (ECL)-reagent
(PJK, Kleinbittersdorf, Germany). For loading control, mouse
actin-specific antibodies (Sigma Aldrich) were used. In some
experiments, mouse anti-human HIF-2a specific antibodies were
used (NB 100–132; Novus Biologicals, Littleton, CO, USA).
To detect HIF-1a protein in infected cells, high-amplification
immunohistochemistry was used as described previously [44].
HeLa-229 cells or NHEKs were seeded on coated glass slides
(Superfrost Plus, Menzel, Germany) the day before infection. Four
hours upon infection, cells were fixed with freshly prepared 3.75%
paraformaldehyde (PFA; pH 7.4; dissolved in PBS) for 30 minutes
and rinsed in PBS. Antigen retrieval was performed for 2 minutes
in preheated target retrieval solution (Dako) using a pressure
cooker. For detection of HIF-1a, monoclonal mouse anti-human
HIF-1a (a67; Novus) and biotinylated secondary anti-mouse
antibodies (Dako) were used. For signal amplification and
visualisation, a catalyzed signal amplification system (CSA-Kit,
Dako) based on a streptavidin-biotin-peroxidase reaction was used
according to the manufacturers instructions. Between incubations,
specimens were washed two to three times (50 mmol/L Tris-HCl,
300 mmol/L NaCl, 0.1% Tween-20, pH 7.6). DAB was used as
chromogen for peroxidase-reaction. Untreated cells were used as
negative controls.
Reporter assays were carried out using the dual-luciferase
reporter assay (Promega, Mannheim, Germany). A pGL3-based
hypoxia responsive element (HRE) plasmid containing four
tandem HIF-1 enhancer sequences from the 39-region of the
erythropoietin gene upstream of the firefly luciferase gene [11] was
cotransfected with a plasmid encoding a Renilla luciferase reporter
construct for normalization [45]. Cells were transiently transfected
using the ExGen 500 in vitro Transfection Reagent (Fermentas, St.
Leon-Rot, Germany) and incubated for 24 hours under cell
culture conditions. Cells were lysed four to six hours after infection
with Passive-Lysis-Buffer (Promega). HIF-1-dependent luciferase
activities normalized to Renilla activity were determined using a
Packard TopCount NXT (BioScience, Groningen, Netherlands).
RNA isolation, Reverse Transcription of Messenger RNA
and Polymerase Chain Reaction
Total RNA of control and infected cells was isolated with the
RNeasy Mini Kit (Qiagen, Hilden, Germany). To remove
contaminating DNA from RNA preparations, the Turbo DNA-
free
TMKit (Applied Biosystems, Darmstadt, Germany) was used.
Reverse transcription was carried out using SuperScript
TM III
Reverse Transcriptase (Invitrogen, Karlsruhe, Germany), RNa-
seOUT
TM Recombinant Ribonuclease Inhibitor (Invitrogen),
oligo-d (pT) 18 mRNA primers (New England Biolabs, Frankfurt
am Main, Germany) and nucleotides (10 mmol/L dNTP Mix;
Fermentas, St. Leon-Rot, Germany). HIF-1a, VEGF and actin
gene expression was quantified using a Light Cycler 480 System
(Roche Diagnostics, Mannheim, Germany). Primers and standard
probes were obtained from LC Search (Heidelberg, Germany) as
described earlier [11].
Detection of Cellular Hypoxia and Oxygen Consumption
NHEKs and HeLa-229 cells were cultivated using conventional
polystyrene dishes or special gas-permeable dishes (Lumox;
Greiner Bio-One, Frickenhausen, Germany) with a hydrophilic
tissue culture treated bottom membrane as described [46]. The
pO2 (mmHg) was quantified in the medium of infected or
uninfected control cells using the blood gas analyzer ABL-77,
sensor cassettes and calibration packs (Radiometer, Willich,
Germany). For internal control, cells were harvested in parallel
four to six hours after infection, and whole cell extracts were
prepared for the detection of HIF-1 activation by immunoblotting
as described above.
Detection of hypoxia was also displayed by visualization of the
hypoxic cell state using the hypoxia-sensitive marker pimonidazole
hydrochloride (Natural Pharmacia International, Burlington,
USA). Pimonidazole hydrochloride (which is a 2-nitroimidazole)
forms adducts with thiol groups in proteins, peptides and amino
acids in hypoxic cells (pO2 ,10 mmHg) [47]. Here, 200 mmol/L
pimonidazole hydrochloride (Hypoxyprobe-1) was added to
HeLa-229 cells immediately before infection as described earlier
[7]. After six hours of infection, cellular hypoxia was visualized
using a primary monoclonal antibody IgG1 that detects protein
adducts of pimonidazole in hypoxic cells (Hypoxyprobe-1Mab1;
NPI, Burlington, USA) and secondary Cy3-conjugated goat anti-
mouse IgG antibodies (Dianova, Hamburg, Germany). Visualiza-
tion was performed using a Leica DM IRE2 confocal laser
scanning microscope (CLSM; Leica Microsystems, Wetzlar,
Germany).
Intraperitoneal infection of mice with S. aureus
Female NMRI mice (33–35 g) were infected intraperitoneally
with S. aureus 8325-4 or S. aureus ermBVhemB 8325-4 (SCV) by
injecting 0,3610
7 bacteria/g body weight in conditioned medium,
as described before [24]. To study the role of HIF-1 in vivo, mice
were inoculated additionally with the HIF-1 inhibitor 17-DMAG
(25 mg/g body weight; application 24 and 16 hours before
infection) as described previously [25]. Survival rates were
measured half-hourly. Peritoneal HIF-1a activation was analyzed
by immunoblotting of the shock-frozen peritoneal specimens using
the Nuclear Extract Kit (Active Motif; Rixensart, Belgium), a
mouse monoclonal anti-HIF-1a (H1a67) antibody (Novus Biolog-
icals, Littleton, USA) and horseradish peroxidase (HRP)-conju-
gated rabbit anti-mouse IgG antibodies (Dako). Signals were
visualized with the enhanced chemiluminescent (ECL)-reagent
(PJK). Normalization of the samples used for immunoblotting was
performed using a Pierce protein quantification assay (BCA
Protein Assay; Thermo Fisher Scientific, Bonn, Germany).
Intravenous infection of mice with S. aureus
Mouse infection experiments were done in accordance with the
animal experiment proposal (H2/06, Tuebingen, Germany,
approved by the Regierungspra ¨sidium Tu ¨bingen, Germany).
The Institutional Animal Care and Use Committee approved this
protocol. Female NMRI mice (33–35 g) were infected intrave-
nously with S. aureus 8325-4 (0,3610
6 bacteria/g body weight)
resuspended in 200 ml conditioned medium as described previ-
ously [23,24]. Seven days after infection, mice were euthanized
and kidneys were taken out when a macroscopically visible abscess
formation had occurred. Organ fixation was performed using
3.75% PBS-buffered (pH 7.4) paraformaldehyde (PFA).
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Formalin-fixed, paraffin-embbed diagnostic skin biposies were
collected from the files of the Department of Dermatology,
University of Tuebingen. Only samples for which a microbiolog-
ical diagnosis of the underlying infection was made in parallel were
included in the study. Microbiological pathogen identification was
performed using standard microbiological techniques [48].
Histology and HIF-1 immunohistochemistry of patient
and murine samples
For murine kidney samples, serial sections (thickness of the
sections: 2 mm) were done and processed by hematoxylin-eosin
and HIF-1a staining. Human samples were processed directly
from paraffin-embedded blocks.
Paraffin sections (2 mm) were dewaxed in xylene, rehydrated in
a series of ethanol washes, and placed in distilled water before
staining procedures. Slides were coated with 3-aminopropyl-tri-
ethoxysylane. For detection of HIF-1a isoforms, a monoclonal
mouse anti-human HIF-1a antibody was used for patient samples
(a67; Novus Biologicals) and polyclonal rabbit anti-mouse HIF-1a
antibodies were used for murine samples (PM16, obtained from a
rabbit immunized with a peptide containing amino acids 553 to
669 of mouse HIF-1a; friendly gift from Patrick Maxwell, Imperial
Hospital, London, UK). Detection of bound antibodies was
performed by using biotinylated secondary anti-mouse (patient
samples) or anti-rabbit (murine samples) antibodies and a
catalyzed signal amplification system (Dako) based on the
streptavidin-biotin-peroxidase reaction, according to the instruc-
tions provided by the manufacturer. Antigen retrieval was
performed for 90 s in preheated target retrieval solution (Dako)
using a pressure cooker. All incubations were performed in a
humidified chamber. Between incubations, specimens were
washed two to four times in buffer (50 mmol/L Tris-HCl,
300 mmol/L NaCl, 0.1% Tween-20, pH 7.6). For counterstain-
ing, hematoxylin-eosin staining of the corresponding section was
done using standard laboratory procedures.
Statistical analysis
For statistical analysis, the unpaired, two-tailed Student t test
was used. Analysis of the survival rates of mice was performed by
Kaplan-Meier analysis using the GraphPad Prism Software
(GraphPad Software Inc., La Jolla, USA). For all assays, a value
of P,0.05 was considered statistically significant.
Supporting Information
Figure S1 Induction of HIF-1 activation in HeLa-229 cells by
bacterial pathogens. Hela-229 cells were seeded on glass slides
infected with P. aeruginosa ATCC 27853 or C. albicans ATCC
90028. HIF-1 activation was detected by nuclear accumulation of
HIF-1a via immunohistochemistry six hours upon infection.
Negative control: uninfected cells; positive control: DFO
(200 mmol/L). Scale bar: 20 mm.
Found at: doi:10.1371/journal.pone.0011576.s001 (1.47 MB TIF)
Figure S2 Induction of HIF-1-dependent gene programming by
bacterial pathogens in HeLa-229 cells. Transcriptional analysis of
(A) VEGF or (B) HIF 1a upon infection. Total mRNA was
prepared four to six hours upon infection, transcribed into cDNA,
and mRNA was quantified by real-time Light-Cycler-PCR (ratio:
VEGF/actin or HIF 1a/actin transcripts; triplicate means given).
* significant difference to control cells (P,0.05).
Found at: doi:10.1371/journal.pone.0011576.s002 (0.82 MB TIF)
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